DURECT Corporation (DRRX)
Largest Insider Buys in Sector
DRRX Stock Price History Chart
DRRX Stock Performance
About DURECT Corporation
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in lipid metabolism, stress and inflammatory responses, and cell death and survival to treat alcohol-associated hepatitis, as well as completed Phase Ib clinical trial to treat patients with nonalcoholic steatohepatitis. In addition, the company offers POSIMIR, a post-surgical pain product to deliver bupivacaine up to days of in adults; and Methydur to treat attention deficit hyperactivity disorder. It markets and sells its ALZET lines through direct sales force in the United States, as well as through a network of distributors in Japan, Europe, and internationally. The company has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation; Indivior UK Ltd.; and Santen Pharmaceutical Co., Ltd. DURECT Corporation was incorporated in 1998 and is headquartered in Cupertino, California.
Insider Activity of DURECT Corporation
Over the last 12 months, insiders at DURECT Corporation have bought $0 and sold $0 worth of DURECT Corporation stock.
On average, over the past 5 years, insiders at DURECT Corporation have bought $218,221 and sold $343,993 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 9,412 shares for transaction amount of $8,000 was made by Robertson Judith J. () on 2022‑08‑18.
List of Insider Buy and Sell Transactions, DURECT Corporation
| 2022-08-18 | 9,411.76 0.0041% | $0.85 | $8,000 | -41.00% | ||||
| 2022-08-17 | 8,130 0.0035% | $0.85 | $6,906 | -42.30% | ||||
| 2022-08-12 | 25,204 0.0101% | $0.71 | $17,993 | -35.13% | ||||
| 2022-08-09 | 79,693 0.037% | $0.69 | $54,661 | -21.85% | ||||
| 2022-05-26 | 65,000 0.0285% | $0.39 | $25,597 | +30.77% | ||||
| 2022-05-24 | 5,000 0.0021% | $0.39 | $1,950 | +26.50% | ||||
| 2022-05-16 | 29,911 0.0142% | $0.41 | $12,201 | +31.58% | ||||
| 2022-05-16 | 1,800 0.0009% | $0.42 | $758 | +31.58% | ||||
| 2022-05-11 | 9,250 0.0041% | $0.40 | $3,700 | +25.00% | ||||
| 2022-05-10 | 2,339 0.001% | $0.41 | $950 | +19.05% | ||||
| 2022-05-09 | 4,250 0.0019% | $0.40 | $1,679 | +28.21% | ||||
| 2022-03-14 | 200,000 0.0937% | $0.59 | $118,000 | -6.36% | ||||
| 2021-12-10 | Sale | Chief Medical Officer | 9,000 0.0041% | $1.05 | $9,495 | |||
| 2021-12-07 | director | 20,000 0.009% | $1.02 | $20,360 | -43.00% | |||
| 2021-05-14 | Sale | Sr. VP Operations & Corp QA | 60,137 0.0003% | $1.72 | $103,682 | -34.01% | ||
| 2020-09-01 | Sale | 10 percent owner | 250,000 0.0012% | $1.68 | $420,000 | +6.89% | ||
| 2020-06-03 | Sale | Sr. VP Operations & Corp QA | 22,956 0.0001% | $2.45 | $56,284 | -18.16% | ||
| 2020-05-26 | Sale | 10 percent owner | 39,388 0.0002% | $2.50 | $98,525 | -24.06% | ||
| 2020-02-06 | 10 percent owner | 75,000 0.0004% | $1.65 | $123,623 | +23.31% | |||
| 2020-02-05 | 10 percent owner | 74,998 0.0004% | $1.69 | $126,777 | +18.24% |
Insider Historical Profitability
| First Eagle Investment Management, LLC | 10 percent owner | 26476546 85.2927% | $0.80 | 2 | 0 | +227.59% |
| Bleichroeder LP | 10 percent owner | 26414656 85.0933% | $0.80 | 3 | 2 | +19.47% |
| 21 APRIL FUND, LTD. | 10 percent owner | 22381546 72.1008% | $0.80 | 11 | 0 | +15.15% |
| THEEUWES FELIX | Chairman and CSO | 3396314 10.941% | $0.80 | 20 | 0 | +41.12% |
| SCHRECK THOMAS A | Chief Financial Officer | 1865000 6.008% | $0.80 | 2 | 0 | +101.37% |
| Robertson Judith J. | 356132 1.1473% | $0.80 | 4 | 0 | <0.0001% | |
| HOFFMANN DAVE | director | 248000 0.7989% | $0.80 | 3 | 0 | +6.97% |
| Maderis Gail J | 200000 0.6443% | $0.80 | 2 | 0 | <0.0001% | |
| SAXE JON S | director | 150000 0.4832% | $0.80 | 8 | 0 | +101.53% |
| BENITO SIMON X | director | 105000 0.3383% | $0.80 | 6 | 0 | +19.36% |
| Farfel Gail M | 100000 0.3221% | $0.80 | 4 | 0 | +25.96% | |
| BROWN JAMES E | President & CEO | 80000 0.2577% | $0.80 | 6 | 1 | +22.33% |
| AZAB MOHAMMAD | 60000 0.1933% | $0.80 | 2 | 0 | +29.04% | |
| CHAN TAI WAH | VP Pharma. Research & Develp. | 51371 0.1655% | $0.80 | 0 | 1 | |
| Neukermans Armand | director | 38000 0.1224% | $0.80 | 5 | 0 | +21.62% |
| Joice Judy R | Sr. VP Operations & Corp QA | 34832 0.1122% | $0.80 | 0 | 2 | |
| TAYLOR MICHAEL J | VP, Non Clinical Research | 24988 0.0805% | $0.80 | 0 | 2 | |
| Arenberg Michael | Chief Financial Officer | 24426 0.0787% | $0.80 | 1 | 0 | +110.63% |
| HOGAN MATTHEW J | Chief Financial Officer | 10000 0.0322% | $0.80 | 1 | 0 | +12.37% |
| Blaschke Terrence F | director | 3000 0.0097% | $0.80 | 2 | 0 | <0.0001% |
| LIU JEAN I | Sr. VP & General Counsel | 0 0% | $0.80 | 0 | 1 | |
| Sussman Norman | Chief Medical Officer | 0 0% | $0.80 | 0 | 1 |
Institutional Investor Ownership
| Ingalls Snyder Llc | $2.44M | 6.5 | 2.02M | -6.03% | -$156,542.58 | 0.11 | |
| The Vanguard Group | $1.31M | 3.48 | 1.08M | +0.72% | +$9,398.07 | <0.0001 | |
| Richmond Brothers, Inc. | $929,696.00 | 2.48 | 768,344 | +48.24% | +$302,560.42 | 1.73 | |
| Gagnon Securities | $459,959.00 | 1.23 | 380,131 | +5.97% | +$25,924.28 | 0.11 | |
| BlackRock | $416,573.00 | 1.11 | 344,275 | +1.6% | +$6,558.20 | <0.0001 | |
| Geode Capital Management | $354,798.00 | 0.94 | 293,150 | +25.08% | +$71,148.41 | <0.0001 | |
| Beirne Wealth Consulting Services, LLC (BWC) | $342,440.00 | 0.91 | 283,008 | -11.57% | -$44,822.07 | 0.15 | |
| Montchanin Asset Management Llc | $327,000.00 | 0.87 | 270,101 | New | +$327,000.00 | 0.33 | |
| Tocqueville Asset Management | $310,026.00 | 0.83 | 256,220 | +10.81% | +$30,249.98 | 0.01 | |
| Gsa Capital Partners Llp | $292,000.00 | 0.78 | 241,669 | New | +$292,000.00 | 0.02 | |
| Dalton Investments | $272,250.00 | 0.73 | 225,000 | -5.2% | -$14,924.14 | 0.17 | |
| Ironwood Investment Management Llc | $256,388.00 | 0.68 | 211,891 | +8.38% | +$19,812.53 | 0.08 | |
| Renaissance Technologies | $201,000.00 | 0.54 | 165,966 | -10.85% | -$24,464.05 | <0.0001 | |
| State Street | $119,045.00 | 0.32 | 98,384 | 0% | +$0 | <0.0001 | |
| Northern Trust | $60,916.00 | 0.16 | 50,344 | 0% | +$0 | <0.0001 | |
| Xtx Topco Ltd | $56,891.00 | 0.15 | 47,017 | +61.16% | +$21,590.19 | <0.01 | |
| Raymond James Associates | $22,385.00 | 0.06 | 18,500 | +25.85% | +$4,598.00 | <0.0001 | |
| Acadian Asset Management | $22,000.00 | 0.06 | 18,520 | -61.37% | -$34,951.73 | <0.0001 | |
| International Assets Investment Management Llc | $16,928.00 | 0.05 | 15,250 | New | +$16,928.00 | <0.0001 | |
| T. Rowe Price | $18,000.00 | 0.05 | 14,210 | 0% | +$0 | <0.0001 | |
| Citadel Advisors LLC | $17,074.00 | 0.05 | 14,111 | -89.92% | -$152,350.75 | <0.0001 | |
| Susquehanna International Group | $15,999.00 | 0.04 | 13,222 | New | +$15,999.00 | <0.0001 | |
| Regis Management Co LLC | $16,000.00 | 0.04 | 13,425 | 0% | +$0 | 0.01 | |
| TWO SIGMA SECURITIES LLC | $13,737.00 | 0.04 | 11,353 | -69.22% | -$30,897.06 | <0.0001 | |
| Two Sigma | $12,584.00 | 0.03 | 10,400 | -61.75% | -$20,317.11 | <0.0001 | |
| Russell Investments Group Ltd | $9,462.00 | 0.03 | 7,820 | 0% | +$0 | <0.0001 | |
| Tower Research Capital | $6,351.00 | 0.02 | 5,249 | +73.01% | +$2,680.03 | <0.0001 | |
| Morgan Stanley | $4,990.00 | 0.01 | 4,124 | 0% | +$0 | <0.0001 | |
| SRS Capital Advisors, Inc. | $4,029.00 | 0.01 | 3,329 | 0% | +$0 | <0.0001 | |
| Advisor Group Holdings Inc | $4,274.00 | 0.01 | 3,533 | -4.49% | -$200.82 | <0.0001 | |
| Blume Capital Management Inc | $3,751.00 | 0.01 | 3,100 | 0% | +$0 | <0.01 | |
| Ancora Advisors Llc | $1,936.00 | 0.01 | 1,600 | -58.97% | -$2,783.00 | <0.0001 | |
| Qube Research & Technologies | $1,598.00 | <0.01 | 1,321 | -30.73% | -$708.88 | <0.0001 | |
| RhumbLine Advisers | $858.00 | <0.01 | 710 | 0% | +$0 | <0.0001 | |
| Wells Fargo | $524.00 | <0.01 | 433 | +5.1% | +$25.41 | <0.0001 | |
| JPMorgan Chase | $132.00 | <0.01 | 109 | -99.16% | -$15,494.86 | <0.0001 | |
| GENWORTH FINANCIAL WEALTH MANAGEMENT INC | $2.00 | <0.01 | 2 | New | +$2.00 | <0.0001 | |
| Newbridge Financial Services Group Inc | $121.00 | <0.01 | 100 | 0% | +$0 | <0.0001 |